904. Outcomes Research: Hemoglobinopathies: Poster II

Thrombotic outcomes in sickle cell disease patients treated with crizanlizumab with or without hydroxyurea A real world retrospective cohort analysis using the trinetx database

Characterizing return to school after pain related hospitalizations and hospital re admission risk in pediatric sickle cell disease

Social isolation and patient reported and healthcare utilization in adults with sickle cell disease

Chorionic villus sampling acceptability and therapeutic abortion compliance in beta thalassemia minor parents A study in low middle income country

Psychiatric comorbidities and the mortality paradox in sickle cell disease A national inpatient analysis

Type 2 diabetes screening and management in individuals with sickle cell disease is compromised by the predominant reliance on glycosylated haemoglobin HbA1c

Impact of preexisting chronic obstructive pulmonary disease on in hospital outcomes in first time acute chest syndrome A nationwide analysis 2016–2022

Data validation and quality framework for building a european multimodal real world dataset for clinical outcome research in sickle cell disease

Rapid immune reconstitution in patients with transfusion dependent thalassemia following betibeglogene autotemcel A real world experience

Patient driven insights in sickle cell disease Results from a global survey informing public health strategies

No overall increased risk of death or cardiovascular disease in individuals with sickle cell trait A prospective study of 467 957 general population adults

Association of social determinants of health SDoH with clinic visit adherence healthcare utilization and hydroxyurea HU acceptance and adherence in children with sickle cell disease SCD

Impact of a near peer group mentorship program on improving transition skills for adolescents and young adults living with sickle cell disease